Mylan NV (MYL)

MYL (NASDAQ:Drugs) EQUITY
$51.39
neg -0.92
-1.76%
Today's Range: 50.95 - 52.91 | MYL Avg Daily Volume: 6,845,600
Last Update: 02/05/16 - 4:00 PM EST
Volume: 4,264,823
YTD Performance: -3.31%
Open: $52.42
Previous Close: $52.31
52 Week Range: $37.59 - $76.69
Oustanding Shares: 491,747,016
Market Cap: 25,703,019,808
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 4
Moderate Buy 0 0 0 0
Hold 5 5 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.00 2.00 2.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 23.86
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
23.86 29.80 29.52
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.24% -1.71% 82.54%
GROWTH 12 Mo 3 Yr CAGR
Revenue 11.70 0.26 0.08
Net Income 48.90 0.73 0.20
EPS 47.70 0.99 0.26
Earnings for MYL:
EBITDA 1.89B
Revenue 7.72B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $1.25 $1.03 $4.35 $4.97
Number of Analysts 6 2 8 8
High Estimate $1.33 $1.03 $4.50 $5.14
Low Estimate $1.21 $1.03 $4.25 $4.82
Prior Year $1.05 $0.70 $3.56 $4.35
Growth Rate (Year over Year) 19.37% 47.14% 22.09% 14.38%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Bret Jensen

 | Jan 19, 2016 | 10:00 AM EST

The year has not started the way most pundits and prognosticators had envisioned.

By

Bret Jensen

 | Jan 7, 2016 | 12:00 PM EST

Mylan and Endo International look like bargains at current prices.

By

Bret Jensen

 | Dec 31, 2015 | 10:00 AM EST

Don't catch falling knives, and don't ignore dividends.

By

David Katz

 | Dec 4, 2015 | 7:00 AM EST

History indicates pharmaceutical companies with low multiples offer payoffs down the road.

By

David Katz

 | Dec 2, 2015 | 7:11 AM EST

Look for 2015's record run of mergers and acquisitions to continue.

By

Bret Jensen

 | Nov 17, 2015 | 9:00 AM EST

These two will continue to churn out earnings growth.

By

Bruce Kamich

 | Nov 16, 2015 | 3:15 PM EST

CAT not going down on bearish news gets us closer to a bottom and buy recommendation.

bearishMylan estimates, target reduced at BMO

Nov 16, 2015 | 8:09 AM EST

Shares of MYL now seen reaching $46, according to BMO Capital. Estimates also cut, given uncertainty around financial trends. Market Perform rating. 

By

Bret Jensen

 | Nov 4, 2015 | 11:47 AM EST
Stocks are trading in a relatively narrow range, but are slightly down after Federal Reserve chair Janet Yellen hinted at a possible December rate hike.
By

Bret Jensen

 | Oct 30, 2015 | 12:09 PM EDT
There's very little movement on Wall Street right now as the European bourses close.
The sharp decline in the index in the first half of January and then the reflexive bounce ...

Nice work on the diary today, Bret. Tough day but you killed it.

Tableau Software option trade opened yesterday on the PHLX stands out as a painful example...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.